항-LAG-3 항체 및 이의 사용 방법

본 발명은 LAG-3(예를 들어, 인간 LAG-3)에 특이적으로 결합하고, LAG-3 기능을 길항시키는 항체를 제공한다. 또한, 이들 항체를 포함하는 약제학적 조성물, 이들 항체를 코딩하는 핵산, 발현 벡터 및 이들 항체를 제조하기 위한 숙주세포, 및 이들 항체를 사용하여 대상체를 치료하는 방법이 제공된다. The instant disclosure provides antibodies that specifically bind to LAG-3 (e.g., human LAG-3) and antagonize LAG-3 function. A...

Full description

Saved in:
Bibliographic Details
Main Authors JENNINGS SHAWN MICHAEL, WILSON NICHOLAS STUART, SAVITSKY DAVID ADAM, VAN DIJK MARC, MUNDT CORNELIA ANNE
Format Patent
LanguageKorean
Published 01.07.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 본 발명은 LAG-3(예를 들어, 인간 LAG-3)에 특이적으로 결합하고, LAG-3 기능을 길항시키는 항체를 제공한다. 또한, 이들 항체를 포함하는 약제학적 조성물, 이들 항체를 코딩하는 핵산, 발현 벡터 및 이들 항체를 제조하기 위한 숙주세포, 및 이들 항체를 사용하여 대상체를 치료하는 방법이 제공된다. The instant disclosure provides antibodies that specifically bind to LAG-3 (e.g., human LAG-3) and antagonize LAG-3 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.
AbstractList 본 발명은 LAG-3(예를 들어, 인간 LAG-3)에 특이적으로 결합하고, LAG-3 기능을 길항시키는 항체를 제공한다. 또한, 이들 항체를 포함하는 약제학적 조성물, 이들 항체를 코딩하는 핵산, 발현 벡터 및 이들 항체를 제조하기 위한 숙주세포, 및 이들 항체를 사용하여 대상체를 치료하는 방법이 제공된다. The instant disclosure provides antibodies that specifically bind to LAG-3 (e.g., human LAG-3) and antagonize LAG-3 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.
Author SAVITSKY DAVID ADAM
WILSON NICHOLAS STUART
JENNINGS SHAWN MICHAEL
MUNDT CORNELIA ANNE
VAN DIJK MARC
Author_xml – fullname: JENNINGS SHAWN MICHAEL
– fullname: WILSON NICHOLAS STUART
– fullname: SAVITSKY DAVID ADAM
– fullname: VAN DIJK MARC
– fullname: MUNDT CORNELIA ANNE
BookMark eNrjYmDJy89L5WTQfDt1ra6Po7uusQKQ9WbTFoXXG_oV3szd8mbuDIU3TWvezFoJFFn5etNUHgbWtMSc4lReKM3NoOzmGuLsoZtakB-fWlyQmJyal1oS7x1kZGBoaWBgbmppYuxoTJwqACL-M7I
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20190075943A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20190075943A3
IEDL.DBID EVB
IngestDate Fri Sep 06 06:14:37 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20190075943A3
Notes Application Number: KR20197012657
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190701&DB=EPODOC&CC=KR&NR=20190075943A
ParticipantIDs epo_espacenet_KR20190075943A
PublicationCentury 2000
PublicationDate 20190701
PublicationDateYYYYMMDD 2019-07-01
PublicationDate_xml – month: 07
  year: 2019
  text: 20190701
  day: 01
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies AGENUS INC
RelatedCompanies_xml – name: AGENUS INC
Score 3.1722026
Snippet 본 발명은 LAG-3(예를 들어, 인간 LAG-3)에 특이적으로 결합하고, LAG-3 기능을 길항시키는 항체를 제공한다. 또한, 이들 항체를 포함하는 약제학적 조성물, 이들 항체를 코딩하는 핵산, 발현 벡터 및 이들 항체를 제조하기 위한 숙주세포, 및 이들 항체를 사용하여 대상체를...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 항-LAG-3 항체 및 이의 사용 방법
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190701&DB=EPODOC&locale=&CC=KR&NR=20190075943A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSU0GtkHNUw10gVWvObCDAsyKlkmWhrppJslJpsbJBsAmN2ijsK-fmUeoiVeEaQQTQw5sLwz4nNBy8OGIwByVDMzvJeDyugAxiOUCXltZrJ-UCRTKt3cLsXVRg_aOgbWbObBv7OJk6xrg7-LvrObsbOsdpOYXBJEDVo-WJsaOzAyswIa0OWgBmGuYE2hfSgFypeImyMAWADQvr0SIgSk7X5iB0xl295owA4cvdMobyITmvmIRBs23U9fq-ji66xorAFlvNm1ReL2hX-HN3C1v5s5QeNO05s2slUCRla83TRVlUHZzDXH20AXaGQ_3Yrx3ELIDjcUYWICd_1QJBoWUlKSU1JQ0YLsgNcUkKTExydzCNNkixcw4OcUkzdLUWJJBBp9JUvilpRm4QFzI8lMZBpaSotJUWWAlW5IkBw4bAEqPiFc
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSU0GtkHNUw10gVWvObCDAsyKlkmWhrppJslJpsbJBsAmN2ijsK-fmUeoiVeEaQQTQw5sLwz4nNBy8OGIwByVDMzvJeDyugAxiOUCXltZrJ-UCRTKt3cLsXVRg_aOgbWbObBv7OJk6xrg7-LvrObsbOsdpOYXBJEDVo-WJsaOzAyswEa2BeikfdcwJ9C-lALkSsVNkIEtAGheXokQA1N2vjADpzPs7jVhBg5f6JQ3kAnNfcUiDJpvp67V9XF01zVWALLebNqi8HpDv8KbuVvezJ2h8KZpzZtZK4EiK19vmirKoOzmGuLsoQu0Mx7uxXjvIGQHGosxsAA7_6kSDAopKUkpqSlpwHZBaopJUmJikrmFabJFiplxcopJmqWpsSSDDD6TpPBLyzNweoT4-sT7ePp5SzNwgaQgS1FlGFhKikpTZYEVbkmSHDicANbLi0c
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%ED%95%AD-LAG-3+%ED%95%AD%EC%B2%B4+%EB%B0%8F+%EC%9D%B4%EC%9D%98+%EC%82%AC%EC%9A%A9+%EB%B0%A9%EB%B2%95&rft.inventor=JENNINGS+SHAWN+MICHAEL&rft.inventor=WILSON+NICHOLAS+STUART&rft.inventor=SAVITSKY+DAVID+ADAM&rft.inventor=VAN+DIJK+MARC&rft.inventor=MUNDT+CORNELIA+ANNE&rft.date=2019-07-01&rft.externalDBID=A&rft.externalDocID=KR20190075943A